A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Halothane
Brofaromine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Brofaromine.
Halothane
Harmaline
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Harmaline.
Halothane
Lormetazepam
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Lormetazepam.
Halothane
Clopenthixol
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Clopenthixol.
Halothane
Doxefazepam
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Doxefazepam.
Halothane
Carbromal
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Carbromal.
Halothane
Reposal
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Reposal.
Halothane
Ethadione
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Ethadione.
Halothane
Penfluridol
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Penfluridol.
Halothane
Tilidine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Tilidine.
Halothane
Dixyrazine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Dixyrazine.
Halothane
Imipramine oxide
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Imipramine oxide.
Halothane
Vinylbital
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Vinylbital.
Halothane
Mephenoxalone
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Mephenoxalone.
Halothane
Fazadinium bromide
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Fazadinium bromide.
Halothane
Cyclobarbital
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Cyclobarbital.
Halothane
Methylpentynol
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Methylpentynol.
Halothane
Vinyl ether
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Vinyl ether.
Halothane
Niaprazine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Niaprazine.
Halothane
Mosapramine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Mosapramine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3